ACE and hypertensive disorder: Moreover, PDAC patients who were prescribed angiotensin converting enzyme inhibitors or angiotensin receptor blockers to treat their hypertension were associated with better clinical outcomes compared to gemcitabine monotherapy (Nakai et al., 2010).